HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis

Georgette D Kanmogne, Kathy Schall, Jessica Leibhart, Bryan Knipe, Howard Eliot Gendelman, Yuri Persidsky

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

Human immunodeficiency virus-1 (HIV-1) encephalitis is characterized by brain infiltration of virus-infected monocytes and macrophages. Cellular products and viral proteins secreted by infected cells likely play an important role in blood-brain barrier (BBB) impairment and the development of HIV-1-associated dementia (HAD). We previously demonstrated that HIV-1 envelope glycoprotein gp120 induces toxicity and alters expression of tight junction proteins in human brain microvascular endothelial cells (HBMECs). Here, we delineate the mechanisms of gp120-induced BBB dysfunction. Human brain microvascular endothelial cells expressed HIV-1 co-receptors (CCR5 and CXCR4). Exposure of HBMECs to gp120 derived from macrophage (CCR5) or lymphocyte (CXCR4)-tropic viruses decreased BBB tightness, increased permeability, and enhanced monocyte migration across in vitro BBB models. Blood-brain barrier integrity was restored after gp120 removal. CCR5 antibodies and inhibitors of myosin light chain kinase or protein kinase C (PKC) blocked gp120-enhanced monocyte migration and permeability of BBB in vitro. Exposure of HBMECs to gp120 induced release of intracellular calcium ([Ca2+]i) that was prevented by CCR5 antibody and partially blocked by CXCR4 antagonist. Human immunodeficiency virus-1 gp120 activated three PKC isoforms in HBMECs [PKC-α/βII, PKC(pan)-βII and PKC-ζ/λ]. Furthermore, specific PKC inhibitors (acting at the ATP-binding and calcium release site) blocked gp120-induced PKC activation and prevented increase in BBB permeability, supporting the biologic significance of these results. Thus, gp120 can cause dysfunction of BBB via PKC pathways and receptor mediated [Ca2+] i release leading to cytoskeletal alterations and increased monocyte migration.

Original languageEnglish (US)
Pages (from-to)123-134
Number of pages12
JournalJournal of Cerebral Blood Flow and Metabolism
Volume27
Issue number1
DOIs
StatePublished - Jan 5 2007

Fingerprint

Blood-Brain Barrier
HIV-1
Monocytes
Protein Kinase C
Endothelial Cells
Brain
Permeability
Macrophages
CCR5 Receptors
CXCR4 Receptors
Viruses
Calcium
Tight Junction Proteins
Myosin-Light-Chain Kinase
Antibodies
Protein C Inhibitor
Viral Proteins
Encephalitis
Protein Kinase Inhibitors
Dementia

Keywords

  • Brain endothelial cells
  • Chemokine receptors
  • HIV-1gp120
  • PKC

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier : Implication for viral neuropathogenesis. / Kanmogne, Georgette D; Schall, Kathy; Leibhart, Jessica; Knipe, Bryan; Gendelman, Howard Eliot; Persidsky, Yuri.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 27, No. 1, 05.01.2007, p. 123-134.

Research output: Contribution to journalArticle

@article{cb39346c6c7941a086e26f22010b6f74,
title = "HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis",
abstract = "Human immunodeficiency virus-1 (HIV-1) encephalitis is characterized by brain infiltration of virus-infected monocytes and macrophages. Cellular products and viral proteins secreted by infected cells likely play an important role in blood-brain barrier (BBB) impairment and the development of HIV-1-associated dementia (HAD). We previously demonstrated that HIV-1 envelope glycoprotein gp120 induces toxicity and alters expression of tight junction proteins in human brain microvascular endothelial cells (HBMECs). Here, we delineate the mechanisms of gp120-induced BBB dysfunction. Human brain microvascular endothelial cells expressed HIV-1 co-receptors (CCR5 and CXCR4). Exposure of HBMECs to gp120 derived from macrophage (CCR5) or lymphocyte (CXCR4)-tropic viruses decreased BBB tightness, increased permeability, and enhanced monocyte migration across in vitro BBB models. Blood-brain barrier integrity was restored after gp120 removal. CCR5 antibodies and inhibitors of myosin light chain kinase or protein kinase C (PKC) blocked gp120-enhanced monocyte migration and permeability of BBB in vitro. Exposure of HBMECs to gp120 induced release of intracellular calcium ([Ca2+]i) that was prevented by CCR5 antibody and partially blocked by CXCR4 antagonist. Human immunodeficiency virus-1 gp120 activated three PKC isoforms in HBMECs [PKC-α/βII, PKC(pan)-βII and PKC-ζ/λ]. Furthermore, specific PKC inhibitors (acting at the ATP-binding and calcium release site) blocked gp120-induced PKC activation and prevented increase in BBB permeability, supporting the biologic significance of these results. Thus, gp120 can cause dysfunction of BBB via PKC pathways and receptor mediated [Ca2+] i release leading to cytoskeletal alterations and increased monocyte migration.",
keywords = "Brain endothelial cells, Chemokine receptors, HIV-1gp120, PKC",
author = "Kanmogne, {Georgette D} and Kathy Schall and Jessica Leibhart and Bryan Knipe and Gendelman, {Howard Eliot} and Yuri Persidsky",
year = "2007",
month = "1",
day = "5",
doi = "10.1038/sj.jcbfm.9600330",
language = "English (US)",
volume = "27",
pages = "123--134",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier

T2 - Implication for viral neuropathogenesis

AU - Kanmogne, Georgette D

AU - Schall, Kathy

AU - Leibhart, Jessica

AU - Knipe, Bryan

AU - Gendelman, Howard Eliot

AU - Persidsky, Yuri

PY - 2007/1/5

Y1 - 2007/1/5

N2 - Human immunodeficiency virus-1 (HIV-1) encephalitis is characterized by brain infiltration of virus-infected monocytes and macrophages. Cellular products and viral proteins secreted by infected cells likely play an important role in blood-brain barrier (BBB) impairment and the development of HIV-1-associated dementia (HAD). We previously demonstrated that HIV-1 envelope glycoprotein gp120 induces toxicity and alters expression of tight junction proteins in human brain microvascular endothelial cells (HBMECs). Here, we delineate the mechanisms of gp120-induced BBB dysfunction. Human brain microvascular endothelial cells expressed HIV-1 co-receptors (CCR5 and CXCR4). Exposure of HBMECs to gp120 derived from macrophage (CCR5) or lymphocyte (CXCR4)-tropic viruses decreased BBB tightness, increased permeability, and enhanced monocyte migration across in vitro BBB models. Blood-brain barrier integrity was restored after gp120 removal. CCR5 antibodies and inhibitors of myosin light chain kinase or protein kinase C (PKC) blocked gp120-enhanced monocyte migration and permeability of BBB in vitro. Exposure of HBMECs to gp120 induced release of intracellular calcium ([Ca2+]i) that was prevented by CCR5 antibody and partially blocked by CXCR4 antagonist. Human immunodeficiency virus-1 gp120 activated three PKC isoforms in HBMECs [PKC-α/βII, PKC(pan)-βII and PKC-ζ/λ]. Furthermore, specific PKC inhibitors (acting at the ATP-binding and calcium release site) blocked gp120-induced PKC activation and prevented increase in BBB permeability, supporting the biologic significance of these results. Thus, gp120 can cause dysfunction of BBB via PKC pathways and receptor mediated [Ca2+] i release leading to cytoskeletal alterations and increased monocyte migration.

AB - Human immunodeficiency virus-1 (HIV-1) encephalitis is characterized by brain infiltration of virus-infected monocytes and macrophages. Cellular products and viral proteins secreted by infected cells likely play an important role in blood-brain barrier (BBB) impairment and the development of HIV-1-associated dementia (HAD). We previously demonstrated that HIV-1 envelope glycoprotein gp120 induces toxicity and alters expression of tight junction proteins in human brain microvascular endothelial cells (HBMECs). Here, we delineate the mechanisms of gp120-induced BBB dysfunction. Human brain microvascular endothelial cells expressed HIV-1 co-receptors (CCR5 and CXCR4). Exposure of HBMECs to gp120 derived from macrophage (CCR5) or lymphocyte (CXCR4)-tropic viruses decreased BBB tightness, increased permeability, and enhanced monocyte migration across in vitro BBB models. Blood-brain barrier integrity was restored after gp120 removal. CCR5 antibodies and inhibitors of myosin light chain kinase or protein kinase C (PKC) blocked gp120-enhanced monocyte migration and permeability of BBB in vitro. Exposure of HBMECs to gp120 induced release of intracellular calcium ([Ca2+]i) that was prevented by CCR5 antibody and partially blocked by CXCR4 antagonist. Human immunodeficiency virus-1 gp120 activated three PKC isoforms in HBMECs [PKC-α/βII, PKC(pan)-βII and PKC-ζ/λ]. Furthermore, specific PKC inhibitors (acting at the ATP-binding and calcium release site) blocked gp120-induced PKC activation and prevented increase in BBB permeability, supporting the biologic significance of these results. Thus, gp120 can cause dysfunction of BBB via PKC pathways and receptor mediated [Ca2+] i release leading to cytoskeletal alterations and increased monocyte migration.

KW - Brain endothelial cells

KW - Chemokine receptors

KW - HIV-1gp120

KW - PKC

UR - http://www.scopus.com/inward/record.url?scp=33845764425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845764425&partnerID=8YFLogxK

U2 - 10.1038/sj.jcbfm.9600330

DO - 10.1038/sj.jcbfm.9600330

M3 - Article

C2 - 16685256

AN - SCOPUS:33845764425

VL - 27

SP - 123

EP - 134

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 1

ER -